Drugs Health Pharma

New cardiovascular risk calculator may impose a burden on 16 million US citizens

HQ Team August 6, 2024: A new cardiovascular disease risk calculator may render 16 million US citizens ineligible for preventive therapy if the.

Read More
Drugs Health Pharma

Contineum’s test drug may reverse multiple sclerosis damage

Contineum Therapeutics, Inc., a US San Diego-headquartered biopharmaceutical company’s trial drug may reverse multiple sclerosis damage by potentially restoring movement and function.

Read More
Drugs Medical Pharma

Oxford spin-off develops new test to detect heart attacks 10 yrs in advance

Caristo Diagnostics, founded by four Oxford University cardiologists, has developed an AI-assisted software that can detect cardiac events a decade in advance.

Read More
Drugs Medical Pharma

Artificial blood vessels can improve heart surgery outcomes: UoE

Flexible, gel-like synthetic tubes can replace human veins during heart bypass operations to reroute blood flow, according to engineers at the University of.

Read More
Drugs Health Pharma

Untreated vision loss, high LDL cholesterol risk factors for dementia

Researchers have added two additional risk factors — untreated vision loss and high LDL cholesterol — to 12 other steps to identify dementia,.

Read More
Drugs Health Pharma

GenX faces a higher risk of 17 cancer types than older generation

Seventeen types of cancer are common in US millennials and the incidence rate for some forms is two to three times higher in.

Read More
Drugs Health Pharma

WHO warns on drug-resistant Klebsiella Pneumonie spread

HQ Team August 4, 2024: The WHO has warned about the rising global incidence of hypervirulent and multi-resistant Klebsiella Pneumoniae (hvKp) infections. The.

Read More
Drugs Health Pharma

US regulator allows GSK’s endometrial cancer therapy for expanded use

The US drug regulator has granted permission for expanded use of British pharmaceutical company, GSK Plc’s endometrial cancer drug.

Read More
Drugs Health Pharma

Adaptimmune’s therapy to treat rare form of cancer gets USFDA nod

UK-based biopharmaceutical company, Adaptimmune Therapeutics Plc, got FDA approval for its cell therapy for treating a rare form of cancer.

Read More
Climate Health Pharma

Africa grapples with a 160% spike in Mpox cases, vaccines a damper

HQ Team August 2, 2024: Mpox or monkeypox cases have seen a 160% surge in the African region this year compared to the.

Read More
X